DuoStim & luteal-phase stimulation
Traditionally, ovarian stimulation starts at the beginning of the cycle, in the so-called follicular phase. Newer data, however, showed that eggs can also be collected from the second half of the cycle, the luteal phase.
On this observation rests double stimulation (DuoStim): two stimulations and two retrievals within the same menstrual cycle. It is a strategy with specific, targeted indications — not for everyone.
What is luteal-phase stimulation?
It is starting ovarian stimulation in the second half of the cycle, after ovulation. It used to be thought that only the first phase of the cycle was suitable; today we know that new waves of follicles develop later too and can respond to stimulation.
An important finding of the studies is that the eggs and embryos obtained from the luteal phase appear to have similar quality and potential — a comparable proportion of euploid blastocysts — to those from the follicular phase.
What exactly is DuoStim?
In DuoStim, after the first follicular-phase stimulation and retrieval, a second stimulation begins immediately in the luteal phase, with a second retrieval a few days later — all within the same cycle.
The aim is to collect more eggs in a very short time. The embryos are frozen and transferred later, in a separate cycle.
What are the main indications?
The strongest indication is when time is pressing and as many eggs or embryos as possible must be accumulated quickly. The classic example is fertility preservation before urgent oncological treatment (e.g. chemotherapy), where there is no luxury of waiting for two separate cycles.
It is also used in some women with poor ovarian response or a low prognosis, when the goal is rapid accumulation of embryos for later transfer or for preimplantation testing.
Does DuoStim increase my chance of having a baby?
Here honesty is needed. DuoStim reliably yields more eggs and embryos in a shorter time. However, it has not been shown to increase the final live-birth rate compared with two conventional, consecutive stimulations.
The available randomized trials show comparable cumulative live-birth rates. That is why the ESHRE guidelines do not recommend it as a general strategy, owing to the lack of strong evidence of superiority.
Is it safe? What are the drawbacks?
DuoStim is generally considered safe, and luteal-phase embryos do not appear inferior. However, it involves more medication, two retrievals in a short interval and a higher cost within the same cycle.
Because the embryos are necessarily frozen, no fresh transfer takes place in the same cycle. The strategy makes sense chiefly when the main objective is speed and number, not immediate transfer.
Whom does it ultimately make sense for?
DuoStim and luteal-phase stimulation are valuable, targeted tools. They have a clear role when time is critical — chiefly in fertility preservation before oncological treatment — and as an option in selected cases of poor response.
But they are not a “better” IVF for the general population. The decision should be taken individually, with a clear explanation of what it offers and what it does not.
Summary
Double stimulation (DuoStim) and luteal-phase stimulation exploit the ability to collect eggs from the second half of the cycle too, with similar embryo quality. Their main advantage is the rapid accumulation of more eggs in a single cycle — ideal for fertility preservation before oncological treatment and for selected poor responders. But they have not been shown to increase the final live-birth rate compared with two conventional stimulations, and ESHRE does not recommend them as a general strategy. They are targeted tools, not a solution for everyone.
⚕ Medically reviewed by Prof. Stratis Kolibianakis · Thessaloniki Medical Association Reg. No. 16340
ARTICLE 6 · IVF
